Skip to main content

Table 2 Factors associated with positive attitude towards PrEP prescription among HIV specialists

From: Attitude towards antiretroviral pre-exposure prophylaxis (PrEP) prescription among HIV specialists

 

Attitude towards PrEP prescription

Total (N = 311)

Odds-ratio for positive attitude towards PrEP prescription

Positive (N = 216)

Negative (N = 95)

N (%)

N (%)

N (%)

OR (95% CI)

MLR-OR (95% CI)

Demographic characteristics and work history

Gender

  Male

122 (56.5)

52 (54.7)

174 (55.9)

1

1

  Female

94 (43.5)

43 (45.3)

137 (44.1)

0.93 (0.57-1.51)

0.85 (0.50-1.45)

Age Class

  ≤40

33 (15.3)

18 (18.9)

51 (16.4)

1

1

  41-50

51 (23.6)

26 (27.4)

77 (24.8)

1.07 (0.51-2.25)

0.68 (0.30-1.56)

  >50

132 (61.1)

51 (53.7)

183 (58.8)

1.41 (0.73-2.73)

1.07 (0.51-2.25)

Length of service (years)

  < 10

35 (16.2)

20 (21.1)

55 (17.7)

1

 

  10-19

71 (32.9)

35 (36.8)

106 (34.1)

1.16 (0.59-2.29)

 

  > = 20

110 (50.9)

40 (42.1)

150 (48.2)

1.57 (0.81-3.03)

 

Workplace

  Non teaching hospital

129 (59.7)

58 (61.1)

187 (60.1)

1

 

  University/Research institute

87 (40.3)

37 (38.9)

124(39.9)

1.06 (0.65-1.73)

 

Prevailing activity

  Ward/Inpatients

116 (53.7)

53 (55.8)

169 (54.3)

1

 

  Outpatient clinic/Day hospital

100 (46.3)

42 (44.2)

142 (45.7)

1.09 (0.67-1.77)

 

Survey

  Online Survey

69 (31.9)

55 (57.9)

124 (39.9)

1

1

  Regional HIV education

147 (68.1)

40 (42.1)

187 (60.1)

2.93 (1.78-4.82)

3.25 (1.79-5.91)

Participants’ experience with HIV-infected patients

Onset of activity with HIV patients

  HAART era

57 (26.4)

34 (35.8)

91 (29.3)

1

 

  Pre-HAART era

159 (73.6)

61 (64.2)

220 (70.7)

1.55 (0.93-2.61)

 

HIV-infected persons currently followed

  < =5

45 (20.8)

19 (20.0)

64 (20.6)

1

 

  6-50

61 (28.2)

28 (29.5)

89 (28.6)

0.92 (0.46-1.85)

 

  >50

110 (50.9)

48 (50.5)

158 (50.8)

0.97 (0.51-1.82)

 

HIV tests prescribed in the last month

  < =5

109 (50.5)

46 (48.4)

155 (49.8)

1

 

  6-20

77 (35.6)

33 (34.7)

110 (35.4)

0.98 (0.58-1.68)

 

  >20

30 (13.9)

16 (16.8)

46 (14.8)

0.79 (0.39-1.59)

 

Practice

Antiretrovirals prescription to HIV negative individuals

  No

26 (12.0)

30 (31.6)

56 (18.0)

1

1

  Yes

190 (88.0)

65 (68.4)

255 (82.0)

3.37 (1.86-6.12)

2.43 (1.29-4.61)

Pre-emptive information on Post-Exposure Prophylaxis

  No

65 (30.1)

44 (46.3)

109 (35,0)

1

1

  Yes

151 (69.9)

51 (53.7)

202 (65,0)

2.00 (1.22-3.30)

1.72 (1.01-2.92)

Knowledge

Self-evaluation of PrEP knowledge

  Poor

73 (33.8)

27 (28.4)

100 (32.1)

1

1

  Sufficient

72 (33.3)

42 (44.2)

114 (36.7)

0.63 (0.35-1.14)

0.87 (0.46-1.66)

  Good

71 (32.9)

26 (27.4)

97 (31.2)

1.01 (0.54-1.90)

1.75 (0.82-3.74)

  1. PrEP, Pre-exposure prophylaxis; HAART, Highly Active Anti-Retroviral Treatment; OR, Odds ratio; MLR-OR, Multiple variable Logistic Regression – Odds Ratio; CI, Confidence Interval.
  2. Boldface = p < 0.05.